Paul J. Tiseo
Direttore Tecnico/Scientifico/R&S presso COGNITION THERAPEUTICS, INC.
Posizioni attive di Paul J. Tiseo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| COGNITION THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 11/10/2022 | - |
Storia della carriera di Paul J. Tiseo
Precedenti posizioni note di Paul J. Tiseo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Formazione di Paul J. Tiseo
| Stony Brook University | Undergraduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Paul J. Tiseo
- Esperienza
